NASDAQ · QTI
QT Imaging Holdings, Inc.
$2.21-$0.07 (-3.07%)
QT Imaging Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.92% below the high.
Loading market information…
NASDAQ · FTRP · USD
Stock price, earnings
Quote as of Aug 17, 2022, 04:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Field Trip Health Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Field Trip Health Ltd., established in 2008 and based in Toronto, Canada, specializes in developing and delivering psychedelic-based therapeutic treatments across North America. The company operates dedicated Field Trip Health Centres providing these therapies, offers digital support through Field Trip Digital applications, and conducts pharmaceutical research via its Field Trip Discovery division, which focuses on creating next-generation psychedelic compounds. Additionally, Field Trip Health Ltd. provides ketamine-assisted therapy to help individuals manage depression, anxiety, addiction, and other related conditions.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| -$1.10-100.0% vs estimate |
| $247.80K |
| Q2 2020 | Dec 1, 2020 | -$0.39 | $71.01K |
|---|
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$2.21-$0.07 (-3.07%)
QT Imaging Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.92% below the high.
$1.12-$0.01 (-0.89%)
Reunion Neuroscience Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.8% below the high.
$2.30-$0.05 (-2.13%)
Cano Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.79% below the high.
$1.51+$0.05 (+3.42%)
Agile Therapeutics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 42.59% below the high.
$1.52-$0.09 (-5.59%)
China Jo-Jo Drugstores, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.22% below the high.
$0.39+$0.03 (+8.48%)
Apexigen, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.35% below the high.
$4.58+$0.22 (+5.05%)
NeuroMetrix, Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.17% below the high.
$0.33+$0.33 (+100.0%)
Centogene N.V.’s quoted price sits in the lower half of its reported 52-week range, 24.24% below the high.
